News
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
Mouth taping for better sleep is trending on TikTok, but you could waste your money, experts say, if you don’t first learn ...
McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...
Diabetes may not only lead to joint pain that can severely damage your knee but also increase the risk of infections and ...
VETS allegedly told a distraught dog owner her beloved Pomeranian was riddled with infection and beyond saving – after they ...
The Butte County Air Quality Management District and Butte County Public Health have issued a joint air quality advisory due ...
Dhaka, the overcrowded capital city of Bangladesh, has ranked 13th on the list of cities with the worst air quality, with an ...
The study led by researchers from the Vardhman Medical College & Safdarjung Hospital, New Delhi, showed that diabetes is a ...
18h
The Weather Network on MSNIndoor PM2.5 spiked above safe levels during June wildfire smoke, report showsPM2.5 levels in homes across Canada surged past WHO guidelines during June's wildfire smoke, data shows. A company that sells internet-connected home air quality monitors says its data shows PM2.5 ...
20h
Zacks.com on MSNMerck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.
Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.
Most of us want to live as long as we can, so we hope for a lengthy lifespan. Age is just a number — we live for a specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results